Fox News has apparently spent only about 20 minutes covering spending cuts to the National Institutes of Health since February 7, when the NIH announced a cap on indirect funding included in research grants. Of the 11 segments about the cuts, Media Matters found only 2 that mentioned the impact they would have on cancer research.
The Trump administration's recent attacks on the NIH have resulted in significant funding cuts, severely impacting cancer research across the country. The cuts include a drastic reduction in the reimbursement rate for indirect costs from an average of 27-28% to a proposed cap of 15%, potentially leading to billions of dollars in losses for research institutions. The funding cuts are affecting a wide range of programs, including precision therapy, quality of life studies, artificial intelligence applications in cancer research, and state clinical trial programs.
Experts warn that these funding reductions could have severe consequences for cancer research and patient care. Some researchers fear that the cuts will lead to delayed discoveries, stalled clinical trials, and a potential exodus of talented scientists from the field, ultimately hindering progress in developing lifesaving treatments for cancer patients.
Pediatric cancer research, which already receives less than 4% of all federal funds for cancer research, is particularly sensitive to these cuts:
Many universities rely on NIH reimbursements to maintain the kind of high-tech facilities and highly trained staff that are necessary to conduct clinical trials and other forms of medical research. Pediatric cancer research, in particular, is often expensive due to the relative rarity of many childhood cancers, the smaller number of patients able to participate in trials, and the need for specialized equipment capable of accommodating the physiology of small children.
“The proposed NIH funding cuts pose a significant threat to the future of pediatric cancer research and could severely impact the progress of life-saving treatments,” Danielle Fragalla, the Chief Executive Officer of Pediatric Cancer Research Foundation, said. “With research institutions facing multi-billion-dollar losses, the ability to fund new and ongoing studies–including those focused on childhood cancer, survivorship, and equitable care–could be drastically reduced.”